Cross-reference: "oclacitinib" — FDA ADE reports ↔ evidence literature
A structural index linking the evidence layer (Europe PMC literature topics) and the FDA adverse-event (ADE) layer (openFDA animal-drug reports) by shared mention of the term "oclacitinib". No new data was fetched; this topic is derived entirely from existing in-repo topics.
FDA ADE report topic
ade_oclacitinib_adverse_events— FDA ADE reports for Oclacitinib — total reports, species & reaction breakdown
Evidence topics referencing "oclacitinib"
evidence_canine_cancer_lymphoma_diet— Evidence cluster — nutrition in canine lymphoma (peer-reviewed, Europe PMC + PubMed)evidence_exotic_rabbit_toxicology— Evidence cluster — Rabbit (Oryctolagus cuniculus) toxicology (peer-reviewed, Europe PMC)
Honest scope note
This is a term-co-occurrence cross-reference: the evidence topics above contain the term "oclacitinib" in their text, and the ADE topic aggregates FDA adverse-event reports for that active ingredient. Co-occurrence is not a clinical assertion that the literature studies the drug's adverse events. Verify against the linked source topics before drawing conclusions.